World's Best Scientists 2026 revealed!
Anne Hagemeijer

Anne Hagemeijer

D-Index & Metrics

Medicine

D-Index
85
Citations
25351
World Ranking
14654
National Ranking
185

Anne Hagemeijer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Anne Hagemeijer sits on this spectrum.

101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 611 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101 publications 1,796+

This scientist: 272 publications — 11th percentile

11% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

Anne Hagemeijer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Anne Hagemeijer sits on this spectrum.

70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 400 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70 D-Index 217+

This scientist: 85 D-Index — 29th percentile

29% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

Overview

Anne Hagemeijer is affiliated with KU Leuven in Belgium, focusing on research primarily within the fields of Medicine and Biochemistry, Genetics and Molecular Biology. Their work encompasses several subfields including Hematology, Molecular Biology, Cancer Research, and Public Health, Environmental and Occupational Health.

The researcher has contributed to studies related to multiple main topics, notably Acute Myeloid Leukemia Research, Epigenetics and DNA Methylation, Cancer Genomics and Diagnostics, Multiple Myeloma Research and Treatments, Acute Lymphoblastic Leukemia research, and RNA modifications and cancer.

Recent publications authored or co-authored by Anne Hagemeijer include:

  • Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients (2021, Clinical Epigenetics)
  • Monosomal karyotype and chromosome 17p loss or TP53 mutations in decitabine-treated patients with acute myeloid leukemia (2020, Annals of Hematology)
  • Correction to: Integrative study of EZH2 mutational status, copy number, protein expression and H3K27 trimethylation in AML/MDS patients (2021, Clinical Epigenetics)

The frequent co-authors collaborating with Anne Hagemeijer include Dietmar Pfeifer, Gabriele Ihorst, Uwe Platzbecker, Michael Lübbert, and Julia Stomper.

Publication outlets where Anne Hagemeijer's work commonly appears are Clinical Epigenetics and Annals of Hematology. Clinical Epigenetics hosts two of their recent publications, while Annals of Hematology features another.

Best Publications

  • KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours

    Maria Debiec-Rychter;Raf Sciot;Axel Le Cesne;Marcus Schlemmer

  • The Apoptosis Inhibitor Gene API2 and a Novel 18q Gene,MLT, Are Recurrently Rearranged in the t(11;18)(q21;q21) Associated With Mucosa-Associated Lymphoid Tissue Lymphomas

    Judith Dierlamm;Mathijs Baens;Iwona Wlodarska;Margarita Stefanova-Ouzounova

  • Translocation of c- abl oncogene correlates with the presence of a Philadelphia chromosome in chronic myelocytic leukaemia

    Claus R. Bartram;Annelies de Klein;Anne Hagemeijer;Ton van Agthoven

  • Acquired mutations in TET2 are common in myelodysplastic syndromes

    Saskia M C Langemeijer;Roland P Kuiper;Marieke Berends;Ruth Knops

  • Monosomal Karyotype in Acute Myeloid Leukemia: A Better Indicator of Poor Prognosis Than a Complex Karyotype

    Dimitri A. Breems;Wim L. J. Van Putten;Georgine E. De Greef;Shama L. Van Zelderen-Bhola

  • Low-Dose Decitabine Versus Best Supportive Care in Elderly Patients With Intermediate- or High-Risk Myelodysplastic Syndrome (MDS) Ineligible for Intensive Chemotherapy: Final Results of the Randomized Phase III Study of the European Organisation for Research and Treatment of Cancer Leukemia Group and the German MDS Study Group

    Michael Lübbert;Stefan Suciu;Liliana Baila;Björn Hans Rüter

  • Mechanisms of resistance to imatinib mesylate in gastrointestinal stromal tumors and activity of the PKC412 inhibitor against imatinib-resistant mutants

    Maria Debiec-Rychter;Jan Cools;Herlinde Dumez;Raf Sciot

  • Fusion of NUP214 to ABL1 on amplified episomes in T-cell acute lymphoblastic leukemia

    C Graux;Jan Cools;C Melotte;H Quentmeier

  • Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/GIMEMAAML-10 trial

    Stefan Suciu;Franco Mandelli;Theo de Witte;Robert Zittoun

  • Use of c-KIT/PDGFRA mutational analysis to predict the clinical response to imatinib in patients with advanced gastrointestinal stromal tumours entered on phase I and II studies of the EORTC Soft Tissue and Bone Sarcoma Group

    M. Debiec-Rychter;H. Dumez;I. Judson;B. Wasag

  • Mitoxantrone versus daunorubicin in induction-consolidation chemotherapy--the value of low-dose cytarabine for maintenance of remission, and an assessment of prognostic factors in acute myeloid leukemia in the elderly: final report. European Organization for the Research and Treatment of Cancer and the Dutch-Belgian Hemato-Oncology Cooperative Hovon Group.

    B. Löwenberg;S. Suciu;E. Archimbaud;H. Haak

  • Gemtuzumab Ozogamicin Versus Best Supportive Care in Older Patients With Newly Diagnosed Acute Myeloid Leukemia Unsuitable for Intensive Chemotherapy: Results of the Randomized Phase III EORTC-GIMEMA AML-19 Trial

    Sergio Amadori;Stefan Suciu;Dominik Selleslag;Franco Aversa

  • Myeloid cell differentiation arrest by miR-125b-1 in myelodysplasic syndrome and acute myeloid leukemia with the t(2;11)(p21;q23) translocation

    Marina Bousquet;Cathy Quelen;Roberto Rosati;Véronique Mansat-De Mas;Véronique Mansat-De Mas

  • Cytogenetics and molecular genetics of T-cell acute lymphoblastic leukemia: from thymocyte to lymphoblast.

    Carlos Graux;Jan Cools;Lucienne Michaux;Peter Vandenberghe

  • Identification of novel fusion partners of ALK, the anaplastic lymphoma kinase, in anaplastic large-cell lymphoma and inflammatory myofibroblastic tumor.

    Jan Cools;Iwona Wlodarska;Riet Somers;Nicole Mentens

  • Gastrointestinal stromal tumours (GISTs) negative for KIT (CD117 antigen) immunoreactivity

    Maria Debiec-Rychter;Bartosz Wasag;Michel Stul;Ivo De Wever

  • A multicenter phase II trial of decitabine as first-line treatment for older patients with acute myeloid leukemia judged unfit for induction chemotherapy

    Michael Lübbert;Björn H. Rüter;Rainer Claus;Claudia Schmoor

  • A new morphologic classification system for acute promyelocytic leukemia distinguishes cases with underlying PLZF/RARA gene rearrangements.

    Danielle Sainty;Vincenzo Liso;Angelo Cantù-Rajnoldi;David Head

  • Clinical and molecular features of FIP1L1-PDFGRA (+) chronic eosinophilic leukemias

    P Vandenberghe;I Wlodarska;L Michaux;P Zachée

  • Hu-ets-1 and Hu-ets-2 genes are transposed in acute leukemias with (4;11) and 8;21) translocations

    N. Sacchi;D. K. Watson;A. H. M. Guerts Van Kessel;A. Hagemeijer

Frequent Co-Authors

Peter Marynen
Peter Marynen KU Leuven
Jan Cools
Jan Cools KU Leuven
Stefan Suciu
Stefan Suciu European Organisation for Research and Treatment of Cancer
Theo de Witte
Theo de Witte Radboud University
Sergio Amadori
Sergio Amadori University of Rome Tor Vergata

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing Medicine in the USA isn’t the only route to a rewarding healthcare career. Thanks to online learning, students can explore various fast-track and advanced nursing programs that offer flexible study options and streamlined pathways into the field.

For those already holding a Master of Science in Nursing (MSN), the shortest msn to dnp program options allow for direct progression toward a Doctor of Nursing Practice (DNP) degree in less time. If you’re looking to balance work and study, dnp online programs provide flexible scheduling along with rigorous preparation for advanced roles.

Entry-level candidates might consider fast track lpn programs to quickly become a Licensed Practical Nurse, which can be a strong foundation for further studies. Those interested in mental health fields can benefit from accelerated msn psychiatric np programs designed to fast-track qualified nurses into psychiatric nurse practitioner roles.

Exploring these pathways can help you find a degree or career track that fits your needs—whether you are looking to upgrade your credentials or start a new journey in healthcare.

Best Scientists Citing Anne Hagemeijer

Trending Scientists

Recently Published Articles